First Time Loading...

Valeo Pharma Inc
TSX:VPH

Watchlist Manager
Valeo Pharma Inc Logo
Valeo Pharma Inc
TSX:VPH
Watchlist
Price: 0.105 CAD -8.7%
Updated: May 3, 2024
Section:
 

Relative Value

The Relative Value of one VPH stock under the Base Case scenario is 0.948 CAD. Compared to the current market price of 0.105 CAD, Valeo Pharma Inc is Undervalued by 89%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

VPH Relative Value
Base Case
0.948 CAD
Undervaluation 89%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.2
P/S
P/S
Price to Sales
0.2
vs History
47
vs Industry
81
Median 3Y
0.7
Median 5Y
0.2
Industry
2.3
Forward
0.2
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-2
Median 5Y
-4.7
Industry
19.8
Forward
-0.5
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-2.4
Median 5Y
-8.8
Industry
10.3
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-2.5
Median 5Y
-5.7
Industry
14.2
More Details
Negative
P/B
P/B
Price to Book Value
N/A
vs History
vs Industry
Median 3Y
-0.4
Median 5Y
-2.6
Industry
1.6
More Details
1.1
EV/S
EV/S
Enterprise Value to Sales
1.1
vs History
47
vs Industry
61
Median 3Y
1.9
Median 5Y
1.1
Industry
3.5
Forward
1
More Details
5.4
EV/GP
EV/GP
Enterprise Value to Gross Profit
5.4
vs History
42
vs Industry
46
Median 3Y
7.5
Median 5Y
5.4
Industry
7.3
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
-5
Median 5Y
-6.3
Industry
11.4
Forward
-23.5
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-4.6
Median 5Y
-5.5
Industry
13.5
Forward
-9.6
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
Median 3Y
-4
Median 5Y
-26.2
Industry
11.5
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-3.3
Median 5Y
-9.3
Industry
12.7
More Details
4.1
EV/IC
EV/IC
Enterprise Value to IC
4.1
vs History
26
vs Industry
18
Median 3Y
4.1
Median 5Y
3.4
Industry
1.5
More Details

Multiples Across Competitors

VPH Competitors Multiples
Valeo Pharma Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Valeo Pharma Inc
TSX:VPH
10.4m CAD 0.2 -0.4 -4 -3.4
CA
Advance Lithium Corp
XTSX:AALI
536.6B CAD 0 -148 717.4 -827 067.9 -827 067.9
US
Viveon Health Acquisition Corp
NYSE-MKT:VHAQ
332.4B USD 0 -692 592.7 -140 273.7 -140 273.7
US
Gould Investors LP
OTC:GDVTZ
304.4B USD 0 0 0 0
US
Carson Energy Development Corp
OTC:CDVM
270.6B USD 263 524.8 -70 424.1 -77 926.9 -77 525.1
NL
Nepi Rockcastle NV
JSE:NRP
77.6B Zac 0 0 0 0
US
Liberty Bancshares Inc
OTC:LBSI
55.5B USD 0 0 0 0
US
Ergo Science Corp
OTC:ERGN
55.2B USD 2 160.3 -12 841.6 -10 816.3 -10 391
US
HK Graphene Technology Corp
OTC:HKGT
53.9B USD 0 -33 104.9 -34 818.3 -34 818.3
ID
Amman Mineral Internasional Tbk PT
IDX:AMMN
708.9T IDR 15.5 40.1 28.7 28.7
US
Myson Group Inc
OTC:MYSN
38.4B USD 0 0 0 0
P/E Multiple
Earnings Growth
CA
Valeo Pharma Inc
TSX:VPH
Average P/E: 40.1
Negative Multiple: -0.4 		N/A
CA
A
Advance Lithium Corp
XTSX:AALI
Negative Multiple: -148 717.4 N/A
US
V
Viveon Health Acquisition Corp
NYSE-MKT:VHAQ
Negative Multiple: -692 592.7 N/A
US
G
Gould Investors LP
OTC:GDVTZ
Not Available N/A
US
C
Carson Energy Development Corp
OTC:CDVM
Negative Multiple: -70 424.1 N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
Not Available
-12%
US
Liberty Bancshares Inc
OTC:LBSI
Not Available N/A
US
Ergo Science Corp
OTC:ERGN
Negative Multiple: -12 841.6 N/A
US
H
HK Graphene Technology Corp
OTC:HKGT
Negative Multiple: -33 104.9 N/A
ID
Amman Mineral Internasional Tbk PT
IDX:AMMN
40.1
N/A
US
M
Myson Group Inc
OTC:MYSN
Not Available N/A
EV/EBITDA Multiple
EBITDA Growth
CA
Valeo Pharma Inc
TSX:VPH
Average EV/EBITDA: 28.7
Negative Multiple: -4 		N/A
CA
A
Advance Lithium Corp
XTSX:AALI
Negative Multiple: -827 067.9 N/A
US
V
Viveon Health Acquisition Corp
NYSE-MKT:VHAQ
Negative Multiple: -140 273.7 N/A
US
G
Gould Investors LP
OTC:GDVTZ
Not Available N/A
US
C
Carson Energy Development Corp
OTC:CDVM
Negative Multiple: -77 926.9 N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
Not Available
21%
US
Liberty Bancshares Inc
OTC:LBSI
Not Available N/A
US
Ergo Science Corp
OTC:ERGN
Negative Multiple: -10 816.3 N/A
US
H
HK Graphene Technology Corp
OTC:HKGT
Negative Multiple: -34 818.3 N/A
ID
Amman Mineral Internasional Tbk PT
IDX:AMMN
28.7
N/A
US
M
Myson Group Inc
OTC:MYSN
Not Available N/A
EV/EBIT Multiple
EBIT Growth
CA
Valeo Pharma Inc
TSX:VPH
Average EV/EBIT: 28.7
Negative Multiple: -3.4 		N/A
CA
A
Advance Lithium Corp
XTSX:AALI
Negative Multiple: -827 067.9 N/A
US
V
Viveon Health Acquisition Corp
NYSE-MKT:VHAQ
Negative Multiple: -140 273.7 N/A
US
G
Gould Investors LP
OTC:GDVTZ
Not Available N/A
US
C
Carson Energy Development Corp
OTC:CDVM
Negative Multiple: -77 525.1 N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
Not Available
13%
US
Liberty Bancshares Inc
OTC:LBSI
Not Available N/A
US
Ergo Science Corp
OTC:ERGN
Negative Multiple: -10 391 N/A
US
H
HK Graphene Technology Corp
OTC:HKGT
Negative Multiple: -34 818.3 N/A
ID
Amman Mineral Internasional Tbk PT
IDX:AMMN
28.7
N/A
US
M
Myson Group Inc
OTC:MYSN
Not Available N/A

See Also

Summary
VPH intrinsic value, competitors valuation, and company profile.
DCF Valuation
VPH stock valuation using Discount Cash Flow valuation method.
Relative Valuation
VPH stock valuation using valuation multiples.
Wall Street Estimates
VPH price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
VPH stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.